SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 40 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $17,720,000 | +97396.6% | 17,750,000 | -4.2% | 0.00% | 0.0% |
| Q4 2022 | $18,175 | -99.9% | 18,522,000 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $17,967,000 | -16.0% | 18,522,000 | -16.3% | 0.00% | 0.0% |
| Q2 2022 | $21,398,000 | -1.0% | 22,116,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $21,609,000 | -1.9% | 22,116,000 | -0.1% | 0.00% | 0.0% |
| Q4 2021 | $22,019,000 | -7.4% | 22,140,000 | -8.2% | 0.00% | 0.0% |
| Q3 2021 | $23,788,000 | +6.2% | 24,115,000 | +6.7% | 0.00% | 0.0% |
| Q2 2021 | $22,401,000 | -13.0% | 22,606,000 | -15.0% | 0.00% | 0.0% |
| Q1 2021 | $25,763,000 | -31.2% | 26,580,000 | -33.1% | 0.00% | -50.0% |
| Q4 2020 | $37,439,000 | +29.5% | 39,727,000 | +26.7% | 0.01% | +20.0% |
| Q3 2020 | $28,904,000 | +64.7% | 31,346,000 | +58.4% | 0.01% | +66.7% |
| Q2 2020 | $17,552,000 | +34.8% | 19,784,000 | +23.0% | 0.00% | 0.0% |
| Q1 2020 | $13,016,000 | -19.0% | 16,089,000 | -9.1% | 0.00% | 0.0% |
| Q4 2019 | $16,070,000 | -61.5% | 17,696,000 | -60.5% | 0.00% | -62.5% |
| Q3 2019 | $41,689,000 | +13.8% | 44,814,000 | +18.5% | 0.01% | +14.3% |
| Q2 2019 | $36,618,000 | – | 37,833,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 37,347,000 | $36,345,000 | 4.44% |
| CAMDEN ASSET MANAGEMENT L P /CA | 51,663,000 | $49,804,000 | 2.44% |
| Wellesley Asset Management | 19,638 | $19,107,000 | 2.29% |
| Radcliffe Capital Management, L.P. | 58,877,000 | $56,759,000 | 2.26% |
| DeepCurrents Investment Group LLC | 29,151,000 | $28,254,000 | 0.97% |
| Penn Mutual Asset Management, LLC | 675,000 | $651,000 | 0.74% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,212,000 | $6,056,000 | 0.71% |
| Sonora Investment Management, LLC | 5,775,000 | $5,568,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 22,802,000 | $22,095,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 23,405,000 | $22,701,000 | 0.19% |